Simalikalactone E (SkE), a New Weapon in the Armamentarium of Drugs Targeting Cancers That Exhibit Constitutive Activation of the ERK Pathway
Oncotarget - United States
doi 10.18632/oncotarget.791
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2012
Authors
Publisher
Impact Journals, LLC